Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.

Zhao JY, Wang HJ, Wang HP, Yao JM, Wu XY, Shang HX, Zhang R, Zhu HG, Dong JJ, Liao L.

Int J Clin Exp Med. 2015 Jul 15;8(7):10731-8. eCollection 2015.

2.

New therapies for dedifferentiated papillary thyroid cancer.

Fallahi P, Mazzi V, Vita R, Ferrari SM, Materazzi G, Galleri D, Benvenga S, Miccoli P, Antonelli A.

Int J Mol Sci. 2015 Mar 17;16(3):6153-82. doi: 10.3390/ijms16036153. Review.

3.

B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1.

Choi YW, Kim HJ, Kim YH, Park SH, Chwae YJ, Lee J, Soh EY, Kim JH, Park TJ.

Exp Mol Med. 2014 Nov 7;46:e120. doi: 10.1038/emm.2014.68.

5.

DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy.

Keller S, Angrisano T, Florio E, Pero R, Decaussin-Petrucci M, Troncone G, Capasso M, Lembo F, Fusco A, Chiariotti L.

Oncol Lett. 2013 Jul;6(1):86-90. Epub 2013 Apr 18.

6.

Genetics and epigenetics of sporadic thyroid cancer.

Vu-Phan D, Koenig RJ.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):55-66. doi: 10.1016/j.mce.2013.07.030. Epub 2013 Aug 8. Review.

7.

Phase I trial of a new schedule of romidepsin in patients with advanced cancers.

Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL.

Clin Cancer Res. 2013 Aug 15;19(16):4499-507. doi: 10.1158/1078-0432.CCR-13-0095. Epub 2013 Jun 11.

8.

Role of metallothioneins in benign and malignant thyroid lesions.

Pula B, Domoslawski P, Podhorska-Okolow M, Dziegiel P.

Thyroid Res. 2012 Dec 28;5(1):26. doi: 10.1186/1756-6614-5-26.

9.

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.

Dom G, Galdo VC, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelar V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren WC.

Thyroid. 2013 Mar;23(3):317-28. doi: 10.1089/thy.2012.0388.

10.

Thyroid cancer: pathogenesis and targeted therapy.

Liebner DA, Shah MH.

Ther Adv Endocrinol Metab. 2011 Oct;2(5):173-95. doi: 10.1177/2042018811419889.

11.

Epigenetics modifications and therapeutic prospects in human thyroid cancer.

Catalano MG, Fortunati N, Boccuzzi G.

Front Endocrinol (Lausanne). 2012 Mar 19;3:40. doi: 10.3389/fendo.2012.00040. eCollection 2012.

12.

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.

Harris PJ, Bible KC.

Expert Opin Investig Drugs. 2011 Oct;20(10):1357-75. doi: 10.1517/13543784.2011.614230. Review.

13.

The role of epigenetic alterations in papillary thyroid carcinogenesis.

Eze OP, Starker LF, Carling T.

J Thyroid Res. 2011;2011:895470. doi: 10.4061/2011/895470. Epub 2011 Jun 14.

14.

DNA methylation in thyroid tumorigenesis.

Stephen JK, Chitale D, Narra V, Chen KM, Sawhney R, Worsham MJ.

Cancers (Basel). 2011 Jun 1;3(2):1732-43. doi: 10.3390/cancers3021732.

15.

Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals.

Kang HJ, Youn YK, Hong MK, Kim LS.

J Korean Med Sci. 2011 Jul;26(7):893-9. doi: 10.3346/jkms.2011.26.7.893. Epub 2011 Jun 20.

16.

Recent advances in molecular diagnosis of thyroid cancer.

Legakis I, Syrigos K.

J Thyroid Res. 2011;2011:384213. doi: 10.4061/2011/384213. Epub 2011 Mar 23.

17.

Epigenetics meets endocrinology.

Zhang X, Ho SM.

J Mol Endocrinol. 2011 Feb;46(1):R11-32.

18.

The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K.

Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. Review.

19.

Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Hou P, Bojdani E, Xing M.

J Clin Endocrinol Metab. 2010 Feb;95(2):820-8. doi: 10.1210/jc.2009-1888. Epub 2009 Dec 11.

20.

Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Pilli T, Prasad KV, Jayarama S, Pacini F, Prabhakar BS.

Thyroid. 2009 Dec;19(12):1333-42. doi: 10.1089/thy.2009.0195. Review.

Supplemental Content

Support Center